(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000 from an existing large pharmaceutical client.
The AIM-traded company said the project would involve updating two previously-developed models with newly-generated clinical...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE